Correlation of HbA1c with atherogenic index of plasma and endothelial dysfunction in type 2 diabetic subjects
Journal Title: International Journal of Clinical Biochemistry and Research - Year 2018, Vol 5, Issue 4
Abstract
Introduction Endothelial dysfunction ED is a well known initial stage of atherosclerosis and cardiovascular disease CVD in general population Recently studies shown increased HbA1c is a marker for cardiovascular risk in subjects with diabetes and without diabetes Atherogenic index of plasma AIP is another risk factor for cardiovascular events Hence the study has been designed to assess the correlation of HbA1c with AIP and ED in type2 diabetic subjects to forecast risk of cardiovascular eventsMaterials and Methods Hundred subjects are enrolled into study with the age of 38 to 58 years among these 50 were type 2 diabetic subjects and 50 were healthy controls HbA1c was estimated by immunoturbidimetric method Nitric oxide NO was measured by kinetic cadmium reduction method and AIP was calculated by standard formula Log triglycerideHDLc Kruskal Wallis test was used to perform statistical variables between the study groups The association between the variables was executed by Pearson correlation testResult HbA1c level was shown to be significantly higher in type2 diabetic subjects than healthy controls Significant lower level of NO was observed in type2 diabetic subjects than healthy controls AIP level was significantly higher in type2 diabetic subjects than healthy controls The present study also observed significant correlation of HbA1c with NO and AIPConclusion We have found that HbA1c has significant correlation with NO and AIP Therefore estimation of HbA1c may be a predictable marker for cardiovascular events in type2 diabetic subjectsKeywords Glycated hemoglobin Atherogenic index of plasma Nitric oxide Cardiovascular disease
Authors and Affiliations
Veluri Ganesh, Palem Siva Prasad
Keywords
Related Articles
- EP ID EP475436
- DOI 10.18231/2394-6377.2018.0123
- Views 93
- Downloads 0
Effect of Hypothyroidism on lipid profile
Objective: To study the effects of subclinical and overt hypothyroidism on serum levels of low density lipoprotein(LDL), total cholesterol(TC), high density lipoprotein (HDL) and triglycerides(TG). And also to compare th...
Uric acid in Type 2 Diabetes mellitus with nephropathy
Introduction: Uric acid is an important antioxidant that contributes for around 60% of free radical scavenging capacity of serum. Its role has been controversial in type 2 diabetes mellitus. Earlier studies have reported...
Serum lactate as a predictor of outcome of sepsis – study
Introduction: Serum Lactate is known to be elevated in subjects with sepsis. Increased blood lactate levels are common in critically ill patients. Some studies revealed its association with prediction of morbidity and mo...
Evaluation of performance of Lipid Accumulation Product (LAP), an obesity index as a marker for diagnosing overt type 2 diabetes mellitus over Body Mass Index (BMI)
Objectives of the study: To compare the indices available to measure obesity such as BMI and “lipid accumulation product” (LAP) with respect to risk for development of Type-II Diabetes mellitus. Methodology: The study de...
A study of serum levels of magnesium and C-Reactive Protein in Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (DM) has emerged as a major public health issue associated with various complications. Patients with metabolic syndrome (MS) have increased risk of developing cardiovascular disease and type 2 di...